Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,244
Closed -$249K 852
2021
Q4
$249K Buy
3,244
+326
+11% +$28.7K 0.01% 766
2021
Q3
$280K Sell
2,918
-170
-6% -$18.6K 0.01% 688
2021
Q2
$330K Buy
3,088
+357
+13% +$35.1K 0.01% 628
2021
Q1
$245K Buy
+2,731
New +$301K 0.01% 681

Other funds holding CRNC

FDx Advisors's CRNC Position: Q1 2022 in Review

FDx Advisors sold out of Cerence (CRNC) in Q1 2022, closing a stake of 3,244 shares — an estimated $249K sold.

FDx Advisors first reported a position in CRNC in Q1 2021 and held it in 4 quarters. The position peaked at $330K in Q2 2021. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

  • FDx Advisors reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
  • FDx Advisors sold 3,244 Cerence shares in Q1 2022, an estimated $249K.
  • FDx Advisors first reported a position in Cerence in Q1 2021 and held it in 4 quarters.
  • FDx Advisors's Cerence position peaked at $330K in Q2 2021.
  • 286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on FDx Advisors's 13F filing for Q1 2022, filed 3 May 2022.